1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42), a novel ALK inhibitor, induces apoptosis and protective autophagy in H2228 cells (vol 72, pg 1370, 2020)

被引：0
|
作者：
Wang, Lijing
Xu, Xiaobo
Liu, Tong
Wang, Junfang
Shen, Jiwei
Guo, Ming
Wu, Yingliang
Zhai, Xin
Zuo, Daiying
机构：
来源：
JOURNAL OF PHARMACY AND PHARMACOLOGY | 2023年 / 75卷 / 05期
关键词：
D O I：
10.1093/jpp/rgad029
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：718 / 718
页数：1
相关论文
共 25 条
  • [21] FT-IR and FT-Raman investigation, quantum chemical studies, molecular docking study and antimicrobial activity studies on novel bioactive drug of 1-(2,4-Dichlorobenzyl)-3-[2-(3-(4-chlorophenyl)-5-(4-(propan-2-yl)phenyl-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5(4H)-ylidence]-2,3-dihydro-1H-indol-2-one
    Viji, A.
    Balachandran, V
    Babiyana, S.
    Narayana, B.
    Salian, Vinutha V.
    JOURNAL OF MOLECULAR STRUCTURE, 2020, 1215 (1215)
  • [22] 5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide:: A [11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride (WAY-100635) positron emission tomography study in humans
    Rabiner, EA
    Wilkins, MR
    Turkheimer, F
    Gunn, RN
    De Haes, JU
    De Vries, M
    Grasby, PM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (03): : 1144 - 1150
  • [23] Discovery of 1-(4-(4-Amino-3-(4-(2-morpholinoethoxy)-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea (CHMFL-FLT3-213) as a Highly Potent Type II FLT3 Kinase Inhibitor Capable of Overcoming a Variety of FLT3 Kinase Mutants in FLT3-ITD Positive AML
    Wang, Aoli
    Li, Xixiang
    Chen, Cheng
    Wu, Hong
    Qi, Ziping
    Hu, Chen
    Yu, Kailin
    Wu, Jiaxin
    Liu, Juan
    Liu, Xiaochuan
    Hu, Zhenquan
    Wang, Wei
    Wang, Wenliang
    Wang, Wenchao
    Wang, Li
    Wang, Beilei
    Liu, Qingwang
    Li, Lili
    Ge, Jian
    Ren, Tao
    Zhang, Shanchun
    Xia, Ruixiang
    Liu, Jing
    Liu, Qingsong
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (20) : 8407 - 8424
  • [24] The Phosphoinositide-Dependent Kinase-1 Inhibitor 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) Prevents Y-Box Binding Protein-1 from Inducing Epidermal Growth Factor Receptor (vol 72, pg 641, 2007)
    To, K.
    Zhao, Y.
    Jiang, H.
    Hu, K.
    Wang, M.
    Wu, J.
    Lee, C.
    Yokom, D. W.
    Stratford, A. L.
    Klinge, U.
    Mertens, P. R.
    Chen, C. S.
    Bally, M.
    Yapp, D.
    Dunn, S. E.
    MOLECULAR PHARMACOLOGY, 2014, 85 (03) : 531 - 532
  • [25] The Phosphoinositide-Dependent Kinase-1 Inhibitor 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) Prevents Y-Box Binding Protein-1 from Inducing Epidermal Growth Factor Receptor (vol 72, pg 641, 2007)
    To, K.
    Zhao, Y.
    Jiang, H.
    Hu, K.
    Wang, M.
    Wu, J.
    Lee, C.
    Yokom, D. W.
    Stratford, A. L.
    Klinge, U.
    Mertens, P. R.
    Chen, C. S.
    Bally, M.
    Yapp, D.
    Dunn, S. E.
    MOLECULAR PHARMACOLOGY, 2016, 90 (01) : 61 - 61
123